Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CERILLIANT™ 3-Methoxytyramine Hydrochloride, 1.0 mg/mL in Methanol (as free base), Sold by MilliporeSigma™ Supelco™

Catalog No. 01001651 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-001-651 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-001-651 Supplier MilliporeSigma Supelco Supplier No. M1711ML
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Certified reference material

3-Methoxytyramine is a metabolite of dopamine, a catecholamine which acts as a neurotransmitter for dopamine receptors and a neurohormone for regulation of numerous brain functions. 3-Methoxytyramine levels can serve as a biomarker for the diagnosis of neuroendocrine tumors such as pheochromocytoma or paraganglioma. This certified solution standard is suitable for LC/MS applications in diagnostic testing, endocrinology, and clinical chemistry.
TRUSTED_SUSTAINABILITY

Specifications

CAS 67-56-1, 1477-68-5
Linear Formula CH3OC6H3-4-(OH)CH2CH2NH2·HCl
MDL Number MFCD00012902
UN Number UN 1230 - class 3 - PG 2 - Methanol, solution
Concentration 1.0 mg/mL in methanol (as free base)
Synonym 3-MT, 3-Methoxy-4-hydroxyphenethylamine, 4-(2-Aminoethyl)-2-methoxyphenol hydrochloride
Formula Weight 203.67
Packaging Ampule
Quantity 1 mL
Flash Point 9.7°C (49.5°F) - closed cup

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.